Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Metoclopramide in Men With Diabetic Gastroparesis
NCT02025751Phase 3Completed
- Sponsor
- Evoke Pharma, Inc.
- Start
- Apr 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic gastroparesis comparing Metoclopramide Nasal Spray with Placebo Nasal Spray (2 arms). Primary endpoint: Gastroparesis Symptom Assessment at 4 weeks. Started Apr 2014; status: completed.
02
Drugs
metoclopramide
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT02025751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025751.